GSK · story · 30 October
GSK · 3 headlines from 3 outlets, on 30 October 2026.
Jefferies moved GSK from Buy to Hold and reduced its price target.
The story's tone is the average of its headlines' own scores. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Average tone of each outlet's headlines in this story, −10 to +10. Impact = headlines × strength of tone.
London South East is the largest at −6.7, ahead of TradingView (−8.3). TradingView is the lowest at −8.3.
Source: MarketFrame news analysis
| outlet | Average tone |
|---|---|
| TradingView | −8.3 |
| MarketScreener | −8.3 |
| London South East | −6.7 |
| Outlet | Headlines | Average tone |
|---|---|---|
| TradingView | 1 | −8.3 |
| MarketScreener | 1 | −8.3 |
| London South East | 1 | −6.7 |
One or two headlines is not a lean: read these as how this story was told, not as a verdict on the outlet.
| Tone | What the article reported, and why it scored that way |
|---|---|
| −8.3 | Broker moves to a less positive rating and cuts target. |
| −8.3 | Broker downgrade with lower price target. |
| −6.7 | Broker downgrade featured in ratings roundup. |
A short, free morning email on how the news treated GSK: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.